In addition, recent studies demonstrate that biomarkers of cardiac injury, including cardiac troponins I (cTnI), cardiac troponin T (cTnT), and N-terminal pro-brain natriuretic peptide (NT-proBNP), are correlated with LVEF measurements in patients with cancer and may predict cardiotoxic complications (4, 5). Here, TNNI3 is linked to cancer.